Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317495 · ClinicalTrials.gov registry record · NA
Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04317495 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 4 participants.
The verdict
NCT04317495, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are highly variable. Given that rTMS is usually given to patients who have failed pharmacotherapy, a more effective alternative is needed. Therefore, this study will combine computerized cognitive training (CCT) during standard rTMS treatments and assess its feasibility, tolerability, and changes in cognitive control performance and depression symptoms. Participants that agree to the study and meet eligibility will receive standard rTMS (generally 25-36 daily treatments) along with CCT (starting on day 5 of treatment until the pre-taper treatment). In addition, to CCT participants will be asked to complete assessments before and after treatment
Interventions
- OTHER Computerized Cognitive Training (CCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-08-27 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04317495
The ClinicalTrials.gov registry entry for NCT04317495 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computerized Cognitive Training (CCT) is the first listed.
NCT04317495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04317495 about?
NCT04317495 is a clinical study titled "Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder". Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are highly variable. Given that rTMS is usually given to patients who have failed pharmacotherapy, a mor...
What is the current status of trial NCT04317495?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-08-27. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT04317495?
The interventions under investigation include: Computerized Cognitive Training (CCT) (OTHER).
Who is sponsoring clinical trial NCT04317495?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.